Top Articles

It is our great pleasure to announce the 2nd edition of the EAN Task Force for Rare Neurologic Diseases Teaching Course, to be organized in Cluj-Napoca (Romania), from 5-7 September 2018. As last year’s event was a success, the Task… Continue Reading

Thank you for hosting applicants of the EAN Clinical Fellowship. How would you evaluate this EAN educational opportunity? The EAN Clinical Fellowship is an excellent opportunity for young neurologists and trainees, to focus on a specific clinical field, and learn / share experience with centres specialised in that field. It is also rewarding for us to meet young, enthusiastic fellows.

João Cid dos Santos was a Portuguese surgeon (Lisbon 1907-1975) devoted to Vascular Surgery. After graduated at University of Lisbon - Faculty of Medicine in 1933 he moved to Strasbourg to practice vascular surgery with René Lerich.

Thank you for hosting applicants of the EAN Clinical Fellowship. How would you evaluate this EAN educational opportunity? This is a super opportunity for trainees in underserved areas and countries to gain practical and valuable experience of management of Parkinson’s disease and other movement disorder in a pragmatic and systematic manner.

In 2016, the EAN president Günther Deuschl and ECTRIMS (European Committee for Treatment and Research in MS) president Xavier Montalban have decided to join the forces of the two societies, and prepare a common guideline for the treatment of multiple sclerosis (MS). In view of the recent increase of medications approved for relapsing- and progressive MS, evidence-based guidance is needed to ensure standardized treatment of MS patients throughout Europe.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

David B Vodušek (DBV): In light of your long-standing experience in the world of neurology world-wide, what would your “diagnosis” be concerning its “state of art”? William Carroll (WC): What a good question to begin with. I would say my “diagnosis” is healthy and its prognosis is one of cautious optimism mixed with exciting opportunities and challenges.

It is a great pleasure to introduce the recipients of the Research Fellowship 2018 (in alphabetical order):

Outcome of the elections of the new Executive During the November 22nd, Board meeting the elections for the EBC new Executive took place. The new Executive is composed as follows: • President Prof. Monica di Luca (FENS)
• 1st Vice… Continue Reading

Situated at the north-eastern end of the Mediterranean basin, Cyprus is the third largest island in the region, with an area of 9,251 square kilometers (3,572 square miles). Cyprus is a small island with a long history and a rich culture that spans 10,000 years, making it one of the oldest civilizations in the Mediterranean area. Situated at the crossroads of three continents - Europe, Asia and Africa - the island’s unique geographic position has played an important part in its turbulent past since antiquity. The island was divided in 1974 following the Turkish invasion.

David B. Vodušek (DBV): The Scientific Panel for Health – SPH is an official and unique panel of the EC within H2020. Can you introduce the SPH to the readers of EAN and explain its tasks? Karin Sipido (KS): The European Commission’s Scientific Panel for Health is a science-led expert group based on the provisions of the Horizon2020 Specific Programme.

Registration for the 4th EAN Congress in Lisbon, Portugal, 16-19 June 2018, is now possible! If you are a member of EAN, you can save up to 200€ – benefit now from our reduced membership fees. Don’t forget to sign… Continue Reading

A new guideline on cerebral venous thrombosis (CVT) diagnosis and treatment issued by the European Stroke Organization (ESO) and endorsed by the European Academy of Neurology (EAN) was recently published in ESO (long version) and EAN (abbreviated version) official journals [1, 2].

The 9th exam of the European Board of Neurology took place in Amsterdam on June 23rd last, one day before the start of the 3rd EAN congress.

Title of the project: “Delineating the molecular mechanisms of mitochondrial DNA disease: clinical and pathological studies”